The College of American Pathologists (CAP) offers a prestigious Laboratory Accreditation Program. Unlike most other accreditations with straightforward requirements, CAP’s accreditation process is dynamic and collaborative and fosters continuous improvement. The accreditation process is so rigorous that CMS granted it deeming authority, allowing CAP inspections in lieu of CMS inspections.
The Centers for Medicare & Medicaid Services (CMS) regulate all non-research laboratories in the U.S. through the Clinical Laboratory Improvement Amendments (CLIA). The CLIA program ensures quality testing and requires laboratories to be certified by their state and CMS.
We take a collaborative and consultative approach with our customers, focusing on removing pain points and creating mutual value.
We provide relevant clinical information and advanced analytical technologies customized to each provider program and patient specimen.
Our staff of experts ensures that state of the art technology is employed. We offer cutting-edge resources for understanding the specific needs of our providers and their patients based on unique biochemistry.
We value long-term relationships, based upon service, reliability, and quick turnaround times.
Our unique approach to the point of care and customer service provides for relevant clinical information and advanced analytical technologies to be applied to each provider program and patient specimen. This ensures that the laboratory test results are optimized for each patient.
Our menu includes testing for drugs of abuse, therapeutic drug monitoring, and molecular testing – most notably COVID-19.
We are licensed in numerous state regulatory programs and adhere to the Clinical Laboratory Improvement Act (CLIA) and Colleges of American Pathologists (CAP) standards and guidelines.